Clinical, epidemiologic characteristics of foreign-born Latinos with HIV/AIDS at an urban HIV clinic.
Latinos represent a growing number of persons with HIV/AIDS in the United States. Reports of clinical features and therapeutic outcomes of this population are limited. We performed a retrospective cohort study of 75 foreign-born Latinos seen at the Grady Infectious Disease Program in Atlanta between January 2000 and August 2002. Of these, 72% were men with a median age of 38.5 years. The most common risk factor for HIV among the men was having sex with men. Median CD4 count at the time of diagnosis was 119/microL. Most were receiving antiretroviral therapy, with 91% achieving an undetectable HIV RNA level. In a multivariable analysis, men were more likely than women to have a history of sexually transmitted infections, to hav received a diagnosis at a lower CD4 count, and to have virologic failure after achieving an undetectable HIV RNA level while receiving antiretroviral therapy. In foreign-born Latinos, HIV disease is usually diagnosed at an advanced stage, but when antiretroviral therapy is administered, many achieve an undetectable HIV RNA level. However, a sustained virologic response is difficult to achieve in men.
Kelley
Colleen F
CF
Department of Medicine, University of California, San Francisco, USA.
Hernandez-Ramos
Isabel
I
Franco-Paredes
Carlos
C
del Rio
Carlos
C
D000328:Adult; D000554:Ambulatory Care Facilities; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D004641:Emigration and Immigration; D005260:Female; D005845:Georgia / Q000453:epidemiology; D015658:HIV Infections / Q000175:diagnosis / Q000453:epidemiology / Q000208:ethnology / Q000503:physiopathology; D006630:Hispanic or Latino; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011787:Quality of Health Care; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D014505:Urban Population; D019562:Viral Load
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors